Ruth Chaplen

Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma

Philip A. Philip, Mark M. Zalupski, V. K. Vaitkevicius et al. · Cancer · 2001 · 135 citations · Full text

Medicine, Oncology, Pharmacology +16

A phase II trial of bryostatin 1 in the treatment of metastatic colorectal cancer.

Jeffrey A. Zonder, Anthony F. Shields, Mark M. Zalupski et al. · PubMed · 2001 · 82 citations

Medicine, Oncology, Pharmacology +14

Phase II Study of Paclitaxel and Carboplatin in Patients With Advanced Gastric Cancer

Shirish M. Gadgeel, Anthony F. Shields, Lance K. Heilbrun et al. · American Journal of Clinical Oncology · 2003 · 65 citations

Medicine, Oncology, Pharmacology +15

Phase II Study of Docetaxel and Celecoxib, a Cyclooxygenase-2 Inhibitor, in Elderly or Poor Performance Status (PS2) Patients with Advanced Non-small Cell Lung Cancer

Shirish M. Gadgeel, Antoinette J. Wozniak, John C. Ruckdeschel et al. · Journal of Thoracic Oncology · 2008 · 12 citations · Full text

Medicine, Oncology, Pharmacology +17

Celecoxib (CEL) and weekly docetaxel (DOC) in elderly or PS2 patients (pts) with advanced non-small cell lung cancer (NSCLC)

Ruth Chaplen, Gregory P. Kalemkerian, A. Wozniak et al. · Journal of Clinical Oncology · 2004 · 10 citations

Medicine, Pharmacology, Pharmacotherapy +16